Published: July 18th, 2024,
Last updated: May 27th, 2025
Edward Zhou, previously an executive at the biotechnology company Cytiva, has been appointed head of the medical technology business in China by the American pharmaceutical group Johnson & Johnson. He succeeds Will Song.